Molecular determinant-based typing of KIR alleles and KIR ligands

Clinical Immunology

Volumn 138, Issue 3, 2011, Pages 274-281

  Bari, Rafijul ^a   Leung, Matthias ^a   Turner, Victoria E ^a   Embrey, Christy ^a   Rooney, Barbara ^a   Holladay, Martha ^a   Leung, Wing ^a,b  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Human leukocyte antigen; Killer cell immunoglobulin like receptor; Natural killer cell; Single nucleotide polymorphism

Indexed keywords

HLA A ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL1; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR LIGAND; LIGAND; UNCLASSIFIED DRUG;

ALLELE; ARTICLE; CONTROLLED STUDY; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN CELL; IMMUNOGENETICS; MOLECULAR TYPING; NATURAL KILLER CELL; POLYMERASE CHAIN REACTION; PREDICTION; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ALLELES; CELL LINE; HLA-A ANTIGENS; HLA-B ANTIGENS; HLA-C ANTIGENS; HUMANS; LIGANDS; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, KIR2DL1; SEQUENCE ANALYSIS, DNA;

EID: 79851508022     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2010.12.002     Document Type: Article

References (29)

1. Lodoen M.B., Lanier L.L. Natural killer cells as an initial defense against pathogens. Curr. Opin. Immunol. 2006, 18:391-398.
2. Cerwenka A., Lanier L.L. Natural killer cells, viruses and cancer. Nat. Rev. Immunol. 2001, 1:41-49.
3. Caligiuri M.A. Human natural killer cells. Blood 2008, 112:461-469.
4. Waldhauer I., Steinle A. NK cells and cancer immunosurveillance. Oncogene 2008, 27:5932-5943.
5. Kim R., Emi M., Tanabe K. Cancer immunoediting from immune surveillance to immune escape. Immunology 2007, 121:1-14.
6. Santoni A., Carlino C., Gismondi A. Uterine NK cell development, migration and function. Reprod. Biomed. Online 2008, 16:202-210.
7. Moffett-King A. Natural killer cells and pregnancy. Nat. Rev. Immunol. 2002, 2:656-663.
8. Lanier L.L. Up on the tightrope: natural killer cell activation and inhibition. Nat. Immunol. 2008, 9:495-502.
9. Long E.O., Colonna M., Lanier L.L. Inhibitory MHC class I receptors on NK and T cells: a standard nomenclature. Immunol. Today 1996, 17:100.
10. Parham P. The genetic and evolutionary balances in human NK cell receptor diversity. Semin. Immunol. 2008, 20:311-316.
11. Robinson J., Marsh S.G. IPD: the immuno polymorphism database. Meth. Mol. Biol. 2007, 409:61-74.
12. Bari R., Bell T., Leung W.H., Vong Q.P., Chan W.K., Das Gupta N., Holladay M., Rooney B., Leung W. Significant functional heterogeneity among KIR2DL1 alleles and a pivotal role of arginine 245. Blood 2009, 114:5182-5190.
13. Yawata M., Yawata N., Draghi M., Little A.M., Partheniou F., Parham P. Roles for HLA and KIR polymorphisms in natural killer cell repertoire selection and modulation of effector function. J. Exp. Med. 2006, 203:633-645.
14. Steiner N.K., Dakshanamurthy S., VandenBussche C.J., Hurley C.K. Extracellular domain alterations impact surface expression of stimulatory natural killer cell receptor KIR2DS5. Immunogenetics 2008, 60:655-667.
15. Goodridge J.P., Lathbury L.J., Steiner N.K., Shulse C.N., Pullikotil P., Seidah N.G., Hurley C.K., Christiansen F.T., Witt C.S. Three common alleles of KIR2DL4 (CD158d) encode constitutively expressed, inducible and secreted receptors in NK cells. Eur. J. Immunol. 2007, 37:199-211.
16. Carr W.H., Pando M.J., Parham P. KIR3DL1 polymorphisms that affect NK cell inhibition by HLA-Bw4 ligand. J. Immunol. 2005, 175:5222-5229.
17. Kulkarni S., Martin M.P., Carrington M. The Yin and Yang of HLA and KIR in human disease. Semin. Immunol. 2008, 20:343-352.
18. Parham P. Taking license with natural killer cell maturation and repertoire development. Immunol. Rev. 2006, 214:155-160.
19. Mandelboim O., Reyburn H.T., Vales-Gomez M., Pazmany L., Colonna M., Borsellino G., Strominger J.L. Protection from lysis by natural killer cells of group 1 and 2 specificity is mediated by residue 80 in human histocompatibility leukocyte antigen C alleles and also occurs with empty major histocompatibility complex molecules. J. Exp. Med. 1996, 184:913-922.
20. Colonna M., Brooks E.G., Falco M., Ferrara G.B., Strominger J.L. Generation of allospecific natural killer cells by stimulation across a polymorphism of HLA-C. Science 1993, 260:1121-1124.
21. Gumperz J.E., Litwin V., Phillips J.H., Lanier L.L., Parham P. The Bw4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB1, a putative HLA receptor. J. Exp. Med. 1995, 181:1133-1144.
22. Kim S., Poursine-Laurent J., Truscott S.M., Lybarger L., Song Y.J., Yang L., French A.R., Sunwoo J.B., Lemieux S., Hansen T.H., Yokoyama W.M. Licensing of natural killer cells by host major histocompatibility complex class I molecules. Nature 2005, 436:709-713.
23. Anfossi N., Andre P., Guia S., Falk C.S., Roetynck S., Stewart C.A., Breso V., Frassati C., Reviron D., Middleton D., Romagne F., Ugolini S., Vivier E. Human NK cell education by inhibitory receptors for MHC class I. Immunity 2006, 25:331-342.
24. D. De Santis, B.A. Foley, E. John, D. Senitzer, F.T. Christiansen, and C.S. Witt, Rapid, flow cytometric assay for NK alloreactivity reveals exceptions to rules governing alloreactivity. Biol. Blood Marrow Transplant. 16 (2010) 179-91.
25. Leung W., Iyengar R., Turner V., Lang P., Bader P., Conn P., Niethammer D., Handgretinger R. Determinants of antileukemia effects of allogeneic NK cells. J. Immunol. 2004, 172:644-650.
26. Leung W., Iyengar R., Triplett B., Turner V., Behm F.G., Holladay M.S., Houston J., Handgretinger R. Comparison of killer Ig-like receptor genotyping and phenotyping for selection of allogeneic blood stem cell donors. J. Immunol. 2005, 174:6540-6545.
27. Triplett B.M., Horwitz E.M., Iyengar R., Turner V., Holladay M.S., Gan K., Behm F.G., Leung W. Effects of activating NK cell receptor expression and NK cell reconstitution on the outcomes of unrelated donor hematopoietic cell transplantation for hematologic malignancies. Leukemia 2009, 23:1278-1287.
28. Hiby S.E., Walker J.J., O'Shaughnessy K.M., Redman C.W., Carrington M., Trowsdale J., Moffett A. Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success. J. Exp. Med. 2004, 200:957-965.
29. Yun G., Tolar J., Yerich A.K., Marsh S.G., Robinson J., Noreen H., Blazar B.R., Miller J.S. A novel method for KIR-ligand typing by pyrosequencing to predict NK cell alloreactivity. Clin. Immunol. 2007, 123:272-280.